Acquisition History / Bain Capital / Mitsubishi Tanabe Pharma Corporation

Bain Capital Acquires Mitsubishi Tanabe Pharma Corporation

Announced February 7, 2025 — $3.36B

Bain CapitalPharmaceuticals2025

What happened

Mitsubishi Tanabe Pharma is the pharmaceutical subsidiary of Mitsubishi Chemical Group. Mitsubishi Chemical announced the agreed sale of the unit to Bain Capital for about ¥510B to focus on turning around its core chemicals business.

Acquirer
Bain Capital
Target
Mitsubishi Tanabe Pharma Corporation
Announced
February 7, 2025
Price
$3.36B
Industry
Pharmaceuticals
Buyer type
Private equity
Backing investors
Bain Capital
Status
Announced, not yet closed

By the numbers

Bain Capital's acquisition history
2nd of 6 tracked deals
Disclosed prices
6 of 6 Bain Capital deals
Bain Capital's average disclosed price
$1.79B
Bain Capital's largest disclosed deal
York Holdings Co., Ltd. ($5.46B)
Tracked acquisitions in 2025
503 across all acquirers
Bain Capital in Pharmaceuticals
1 acquisition

Frequently Asked Questions About This Acquisition

When did Bain Capital acquire Mitsubishi Tanabe Pharma Corporation?

Bain Capital acquired Mitsubishi Tanabe Pharma Corporation on February 7, 2025. This was Bain Capital's 2nd publicly tracked acquisition out of 6 we have on record.

How much did Bain Capital pay for Mitsubishi Tanabe Pharma Corporation?

Bain Capital paid $3.36B for Mitsubishi Tanabe Pharma Corporation.

What does Mitsubishi Tanabe Pharma Corporation do?

Mitsubishi Tanabe Pharma is the pharmaceutical subsidiary of Mitsubishi Chemical Group. Mitsubishi Chemical announced the agreed sale of the unit to Bain Capital for about ¥510B to focus on turning around its core chemicals business.

What other Pharmaceuticals companies has Bain Capital acquired?

Mitsubishi Tanabe Pharma Corporation is Bain Capital's only publicly tracked acquisition in Pharmaceuticals so far.

Read the full article →

More Bain Capital acquisitions

See all 6 Bain Capital acquisitions →

More Pharmaceuticals acquisitions